Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis

INTRODUCTION: Repository corticotropin injection (RCI; Acthar(®) Gel) is indicated for the treatment of acute exacerbations of multiple sclerosis (MS) in adults. Despite the well-documented clinical and economic benefits of RCI, many patients are denied use of the therapy by third-party payers. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Rice, J. Bradford, Panaccio, Mary P., White, Alan, Simes, Mark, Billmyer, Emma, Downes, Nathaniel, Niewoehner, John, Wan, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140003/
https://www.ncbi.nlm.nih.gov/pubmed/33170434
http://dx.doi.org/10.1007/s40120-020-00219-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140003/
https://www.ncbi.nlm.nih.gov/pubmed/33170434
http://dx.doi.org/10.1007/s40120-020-00219-y

Ejemplares similares